Reducing Production Cost of Stemirac Is Key Issue: Nipro Pres.

May 20, 2019
Nipro President Yoshihiko Sano Nipro President Yoshihiko Sano on May 17 expressed concern about the large difference between the NHI price of its stem cell therapy Stemirac for the treatment of spinal cord injury (SCI), which is set at 14,957,755...read more